stata 18 0 software Search Results


version 18 0 for mac  (STATA Corporation)
99
STATA Corporation version 18 0 for mac
Version 18 0 For Mac, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+1%2E0/pm38747153-54-7-11
Average 99 stars, based on 1 article reviews
version 18 0 for mac - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
stata mp 18 0  (STATA Corporation)
99
STATA Corporation stata mp 18 0
Stata Mp 18 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+4%2E0/pm40045270-63-8-8
Average 99 stars, based on 1 article reviews
stata mp 18 0 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
p p38 mapk thr180 tyr182  (Cell Signaling Technology Inc)
97
Cell Signaling Technology Inc p p38 mapk thr180 tyr182
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
P P38 Mapk Thr180 Tyr182, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/Phospho-p38+MAPK+(Thr180%2FTyr182)+Antibody/pmc08138305-48-46-50
Average 97 stars, based on 1 article reviews
p p38 mapk thr180 tyr182 - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier
stata 18 0 13 certainty  (STATA Corporation)
99
STATA Corporation stata 18 0 13 certainty
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Stata 18 0 13 Certainty, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+13%2E0/pm41084884-77-18-18
Average 99 stars, based on 1 article reviews
stata 18 0 13 certainty - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
stata 18 0 software  (STATA Corporation)
99
STATA Corporation stata 18 0 software
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Stata 18 0 Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+8%2E0/pmc11559349-80-6-9
Average 99 stars, based on 1 article reviews
stata 18 0 software - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
minitab 18 0 software  (Minitab Inc)
86
Minitab Inc minitab 18 0 software
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Minitab 18 0 Software, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/1+18+minitab+software/10__1093_slash_fqsafe_slash_fyad065-101-18-18
Average 86 stars, based on 1 article reviews
minitab 18 0 software - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
stata 18 0  (STATA Corporation)
99
STATA Corporation stata 18 0
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Stata 18 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+12%2E0/pm40576444-78-5-7
Average 99 stars, based on 1 article reviews
stata 18 0 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
stata version 18 0  (STATA Corporation)
99
STATA Corporation stata version 18 0
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Stata Version 18 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+10%2E0/pm41316498-93-5-5
Average 99 stars, based on 1 article reviews
stata version 18 0 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
stata se software v 18 0  (STATA Corporation)
99
STATA Corporation stata se software v 18 0
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Stata Se Software V 18 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+3%2E0/pmc12056637-118-5-5
Average 99 stars, based on 1 article reviews
stata se software v 18 0 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
stata version 18 0 16  (STATA Corporation)
99
STATA Corporation stata version 18 0 16
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Stata Version 18 0 16, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+16%2E0/pm40977183-62-5-5
Average 99 stars, based on 1 article reviews
stata version 18 0 16 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
fe software ansys workbench 18.0  (ANSYS inc)
90
ANSYS inc fe software ansys workbench 18.0
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Fe Software Ansys Workbench 18.0, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/ansys+cfx/pmc08317600-72-18-20
Average 90 stars, based on 1 article reviews
fe software ansys workbench 18.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
redcap software 180 version 9 7 5  (STATA Corporation)
99
STATA Corporation redcap software 180 version 9 7 5
Effects of DMF on <t>p38</t> <t>MAPK</t> pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) <t>p38</t> <t>MAPK</t> was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.
Redcap Software 180 Version 9 7 5, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+18+0+software/STATA+9%2E0/pm33774171-55-11-27
Average 99 stars, based on 1 article reviews
redcap software 180 version 9 7 5 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Effects of DMF on p38 MAPK pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) p38 MAPK was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.

Journal: Frontiers in Pharmacology

Article Title: Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition

doi: 10.3389/fphar.2021.684680

Figure Lengend Snippet: Effects of DMF on p38 MAPK pathway. ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) w/or w/o DMF (10 μM) for 24 h (A) p38 MAPK was measured by western blot analysis; band densities were quantified by ImageQuantTL software and normalized values were plotted in the histogram shown on the right (*** p < 0.001 vs. NG; † p < 0.05 vs. untreated/HG; n = 6). (B) ARPE-19 cells exposed to normal glucose (NG) or high glucose (HG) were pretreated with SB202190 (10 µM), a p38 MAPK inhibitor for 30 min and then treated with DMF (10 μM) for 24 h. VEGF levels were measured through ELISA. * p < 0.05 vs. NG untreated cells; n = 6. ( C ) MTT analysis: values are expressed as percentage of cell viability in NG untreated cells. * p < 0.05 or ** p < 0.01 vs. NG untreated cells; n = 6.

Article Snippet: Primary antibodies: BAX (sc-493, Santa Cruz Biotechnology, Inc, CA, United States), Bcl-2 (sc-509, Santa Cruz Biotechnology, Inc, CA, United States), COX-2 (sc-19999, Santa Cruz Biotechnology, Inc, CA, United States), iNOS (sc-651, Santa Cruz Biotechnology, Inc, CA, United States), p38 MAPK (#9212, Cell Signaling Technology, United States), p-p38 MAPK (Thr180/Tyr182) (#9211, Cell Signaling Technology, United States) and β -tubulin (sc-9104, Santa Cruz Biotechnology, Inc, CA, United States).

Techniques: Western Blot, Software, Enzyme-linked Immunosorbent Assay